FDA proposes unique ID system for devices; Northwestern develops super-flexible implantables;

@FierceMedDev: CareFusion has staged a Class I recall of some of its infant breathing devices. Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: Roche continues to expand its diagnostics business with an FDA nod for a new HIV test. Story | Follow @DamianFierce

> The FDA is proposing every medical device marketed in the U.S. feature a unique ID tag, looking to improve reporting of adverse events and device safety. The agency will seek comment on the proposal for 120 days. Statement

> W.L. Gore has received a CE mark for expanded sizes of its Excluder AAA endoprosthesis, a device designed to treat abdominal aortic aneurysm. More

> Researchers at Northwestern University have developed electronics that can stretch to more than 200% their original size, a development that could lead to super-flexible medical devices. Article

> Syneron Medical ($ELOS) has received FDA clearance for its Elos Plus system, a multi-platform dermatological tech used in aesthetic procedures. The device is already available in Europe and Asia. News

> ProPep Surgical received 510(k) clearance for its nerve monitoring system, an intraoperative tech designed to accompany robotic prostate cancer surgery. Release

Pharma News

 @FiercePharma: Jefferies analysts like India's Cipla, Ranbaxy, Sun Pharma, because of emerging markets sales. Item | Follow @FiercePharma

> Will Amylin buy favor AZ's Simon Lowth in CEO contest? More

> Purdue aims to extend OxyContin monopoly with test in kids. Article

> Icahn looks askance at Forest CEO's stock trading. Story

Biotech News

 @FierceBiotech: Researchers shatter record with U.S.-China genomic data transfer. News | Follow @FierceBiotech

 @JohnCFierce: Rodman's Michael King says 'whoops' on Amylin, believes Vivus and MannKind (huh?) next likely diabetes targets. Item | Follow @JohnCFierce

 @RyanMFierce: A good job rounding up the early-stage biotech VC usual suspects. More | Follow @RyanMFierce

> GlobeImmune's $69M IPO designed to build immunotherapy pipeline. Article

> In R&D showdown, Genentech beat Roche in a TKO. Story

> J&J rushes drug-resistant TB therapy bedaquiline to FDA. News

Biotech Research News

> Promising mouse study lays foundation for startup's autism drug program. Article

> In breakthrough, stem cell transplants reverse diabetes in mice. Story

> Texas cancer research funding effort may shift to startups. Item

> Mayo Clinic researchers find novel way to repair MS damage. News

Pharma Manufacturing News

> GlaxoSmithKline's Witty says manufacturing must become more efficient. More

> J&J recalls 69,000 units of K-Y vaginal lubricant. News

> United snags Glaxo buildings as it completes expansion. Story

> ScinoPharm building new cancer injectables plant in China. Article

Biomarkers News

> Marker helps docs pick kids' bone cancer treatment. Story

> Developing proteomic signatures focus pancreatic cancer therapy. Article

> Heart size distorts biomarker levels. More

> Apolipoproteins mark diabetic visual loss. Item

> Biomarkers spot hep C liver disease. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.